The Canadian PressApril 15, 2014 10:02
A turnaround in Johnson
The world's biggest maker of health care products beat Wall Street expectations and raised its earnings outlook Tuesday. The maker of Band-Aids and biologic drugs said net income was $4.73 billion, or $1.64 per share, up from $3.5 billion, or $1.22 per share, a year earlier.
Excluding one-time items, income was $4.43 billion, or $1.54 per share. Analysts expected $1.48.
The New Brunswick, N.J., company said revenue totalled $18.12 billion, up 3.5 per cent. Analysts expected $18.04 billion.